Changes of dendritic cells in prostate cancer and dendritic cell-based immunotherapy / 中华男科学杂志
National Journal of Andrology
;
(12): 453-456, 2007.
Article
in Chinese
| WPRIM
| ID: wpr-297703
ABSTRACT
As the potent professional antigen present cell, dendritic cells (DC) play an important role in the initiation for anti-tumor immunity. Prostate cancer (PCa) can reduce the number and function of tumor infiltrated dendritic cells (TIDC) by a series of complicated mechanisms, escaping from immunosurveillance. With the development of immunology, more and more studies focus on TIDC and DC-based vaccines for PCa. However, all these studies are still at the exploratory stage. Here is a review of the related literature.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prostatic Neoplasms
/
Therapeutics
/
Dendritic Cells
/
Cancer Vaccines
/
Cell Biology
/
Therapeutic Uses
/
Allergy and Immunology
/
Immunotherapy
Limits:
Humans
/
Male
Language:
Chinese
Journal:
National Journal of Andrology
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS